Daikaffil Chemicals India Ltd's Board of Directors, at its meeting held on July 14, 2026, approved Revised Audited Consolidated Financial Results for the quarter and financial year ended March 31, 2026. The revision was carried out solely to incorporate the Consolidated Statement of Cash Flows, which had been omitted from the results originally approved on May 28, 2026. The company clarified that there is no change whatsoever in the financial performance, financial position, or any other financial information contained in the previously approved Consolidated Financial Results.

Financial Performance for FY26

The consolidated results for the year ended March 31, 2026, reflect a challenging operating environment, with total expenses significantly exceeding total income. The following table summarises the key financial metrics for the year and the quarter ended March 31, 2026, alongside the quarter ended December 31, 2025 (all figures in ₹ Lakhs):

For the full year FY26, cost of materials consumed stood at ₹978.64 lakhs, representing the largest expense component, followed by other expenses of ₹386.00 lakhs and employee benefits expense of ₹172.16 lakhs. No current tax was applicable for the year, while a deferred tax credit of ₹4.21 lakhs was recorded.

Balance Sheet Highlights as at March 31, 2026

The consolidated balance sheet as at March 31, 2026, reflects total assets of ₹941.70 lakhs, supported by equity share capital of ₹600.00 lakhs and other equity of ₹77.62 lakhs. Key balance sheet figures are presented below (all figures in ₹ Lakhs):

Consolidated Cash Flow Statement for FY26

The Revised Consolidated Financial Results incorporate the Consolidated Statement of Cash Flows for the year ended March 31, 2026, prepared using the indirect method. Key cash flow figures are as follows (all figures in ₹ Lakhs):

The net cash inflow from operating activities of ₹59.48 lakhs was supported by a decrease in trade and other receivables of ₹406.52 lakhs and a decrease in inventories of ₹58.71 lakhs, partially offset by a decrease in trade payables of ₹311.33 lakhs. Net cash used in investing activities amounted to ₹39.07 lakhs, primarily on account of purchase of fixed assets including capital work-in-progress of ₹41.47 lakhs.

Revision Background and Regulatory Context

The revision to the Consolidated Financial Results was necessitated following a communication from BSE Limited dated June 30, 2026, regarding the levy of a fine under the SEBI Master Circular for non-submission of the Consolidated Statement of Cash Flows along with the original results filed on May 28, 2026. The company had initially held the view that, in the absence of an opening Consolidated Balance Sheet, the consolidated cash flow statement could not be prepared. Following observations from the Exchange and after obtaining professional advice on the applicability of Indian Accounting Standard (Ind AS) 7, the company prepared the Consolidated Statement of Cash Flows using the indirect method, reconciling the movement between the Opening Standalone Financial Statements and the Closing Consolidated Financial Statements.

The Board noted that the revision is limited solely to the inclusion of the Consolidated Statement of Cash Flows and consequential disclosures, with no change to any financial performance or position data. The Audited Standalone Financial Results approved on May 28, 2026, remain unchanged and were not resubmitted. Statutory auditors M/s. N V C & Associates LLP, Chartered Accountants, have issued an unmodified opinion on the Revised Consolidated Financial Results. The Group operates in the manufacturing of OBA and other chemicals, and its business activity falls within a single business segment. The subsidiary, Mikusu Global Industries Limited, was incorporated on August 22, 2025, making FY26 the first year for which consolidated financial statements have been prepared; accordingly, comparative figures for the quarter and year ended March 31, 2025, are not presented.

Mikusu India Private Limited has increased its shareholding in Daikaffil Chemicals India Limited to 49.62% through an open market acquisition. The acquirer purchased 13,139 equity shares on June 16, 2026, representing 0.22% of the total paid-up share capital of the target company. These transactions were disclosed to BSE Ltd under Regulation 29 of the SEBI (Substantial Acquisition of Shares and Takeover) Regulations, 2011.

Prior to this acquisition, Mikusu India Private Limited held 29,64,128 equity shares, accounting for 49.40% of the share capital. Following the purchase, the total holding stands at 29,77,267 equity shares. The acquirer is classified as part of the promoter group of Daikaffil Chemicals India Limited.

The equity share capital of Daikaffil Chemicals India Limited remains at Rs. 6,00,00,000, comprising 60,00,000 equity shares of Rs. 10 each. The total diluted share capital also remains unchanged at this level. There were no changes to the holdings of warrants, convertible securities, or encumbered shares as part of these transactions.

Shareholding Details

The following table outlines the changes in shareholding for Mikusu India Private Limited:

The disclosures were signed by Raghuram K Shetty, Director of Mikusu India Private Limited, on June 17, 2026.